WITH n: 658 f: 1.5e-02 bk_f: 1.0e-02 p: -44.56 PROTEIN n: 486 f: 1.1e-02 bk_f: 5.3e-03 p: -102.76 PROTEINS n: 318 f: 7.0e-03 bk_f: 2.6e-03 p: -121.07 COMPLEX n: 276 f: 6.1e-03 bk_f: 1.1e-03 p: -244.65 CELL n: 181 f: 4.0e-03 bk_f: 2.5e-03 p: -21.84 INTERACTION n: 164 f: 3.6e-03 bk_f: 7.0e-04 p: -141.42 DOMAIN n: 163 f: 3.6e-03 bk_f: 1.2e-03 p: -74.56 BINDING n: 163 f: 3.6e-03 bk_f: 1.7e-03 p: -40.50 FROM n: 144 f: 3.2e-03 bk_f: 5.8e-03 p: -34.96 FUNCTION n: 136 f: 3.0e-03 bk_f: 1.2e-03 p: -49.12 REQUIRED n: 134 f: 3.0e-03 bk_f: 9.2e-04 p: -68.06 BETWEEN n: 129 f: 2.8e-03 bk_f: 1.6e-03 p: -20.58 KINASE n: 125 f: 2.8e-03 bk_f: 8.9e-04 p: -59.70 ON n: 110 f: 2.4e-03 bk_f: 3.9e-03 p: -18.49 IDENTIFIED n: 102 f: 2.3e-03 bk_f: 1.1e-03 p: -25.93 INTERACT n: 97 f: 2.1e-03 bk_f: 2.6e-04 p: -124.16 TWO-HYBRID n: 96 f: 2.1e-03 bk_f: 2.2e-04 p: -132.77 ESSENTIAL n: 96 f: 2.1e-03 bk_f: 6.6e-04 p: -48.70 TRANSCRIPTION n: 93 f: 2.1e-03 bk_f: 1.1e-03 p: -16.68 VITRO n: 92 f: 2.0e-03 bk_f: 1.0e-03 p: -21.31 INTERACTIONS n: 88 f: 1.9e-03 bk_f: 3.9e-04 p: -73.49 ROLE n: 87 f: 1.9e-03 bk_f: 8.9e-04 p: -23.65 SHOW n: 85 f: 1.9e-03 bk_f: 8.1e-04 p: -26.36 ACTIVATION n: 77 f: 1.7e-03 bk_f: 7.4e-04 p: -23.79 FACTOR n: 75 f: 1.7e-03 bk_f: 7.8e-04 p: -19.89 SUGGESTING n: 70 f: 1.5e-03 bk_f: 5.0e-04 p: -35.13 TRANSCRIPTIONAL n: 66 f: 1.5e-03 bk_f: 5.1e-04 p: -29.36 DOMAINS n: 65 f: 1.4e-03 bk_f: 4.7e-04 p: -31.88 COMPLEXES n: 65 f: 1.4e-03 bk_f: 3.2e-04 p: -49.36 SUBUNITS n: 59 f: 1.3e-03 bk_f: 4.1e-04 p: -30.47 DEMONSTRATE n: 59 f: 1.3e-03 bk_f: 3.7e-04 p: -34.65 ENCODES n: 58 f: 1.3e-03 bk_f: 4.9e-04 p: -22.86 PATHWAY n: 57 f: 1.3e-03 bk_f: 6.0e-04 p: -15.40 FUNCTIONS n: 54 f: 1.2e-03 bk_f: 4.0e-04 p: -25.73 INTERACTS n: 52 f: 1.1e-03 bk_f: 1.7e-04 p: -57.23 COMPONENTS n: 51 f: 1.1e-03 bk_f: 2.9e-04 p: -33.71 COMPONENT n: 50 f: 1.1e-03 bk_f: 2.7e-04 p: -35.45 BINDS n: 42 f: 9.3e-04 bk_f: 2.7e-04 p: -24.74 ASSOCIATION n: 42 f: 9.3e-04 bk_f: 2.2e-04 p: -30.62 PHOSPHORYLATION n: 41 f: 9.1e-04 bk_f: 3.3e-04 p: -17.79 BIND n: 40 f: 8.8e-04 bk_f: 3.0e-04 p: -19.98 OVEREXPRESSION n: 38 f: 8.4e-04 bk_f: 2.1e-04 p: -27.21 TERMINUS n: 37 f: 8.2e-04 bk_f: 2.1e-04 p: -25.22 ASSEMBLY n: 37 f: 8.2e-04 bk_f: 2.5e-04 p: -21.12 C-TERMINAL n: 35 f: 7.7e-04 bk_f: 2.8e-04 p: -15.63 DIRECTLY n: 34 f: 7.5e-04 bk_f: 2.3e-04 p: -19.03 DEFECTIVE n: 34 f: 7.5e-04 bk_f: 2.5e-04 p: -17.85 SCREEN n: 33 f: 7.3e-04 bk_f: 1.5e-04 p: -28.18 EXPRESSION n: 33 f: 7.3e-04 bk_f: 1.6e-03 p: -16.62 BIOCHEMICAL n: 33 f: 7.3e-04 bk_f: 2.2e-04 p: -19.53 TOGETHER n: 32 f: 7.1e-04 bk_f: 2.4e-04 p: -15.91 LOCALIZATION n: 31 f: 6.8e-04 bk_f: 2.3e-04 p: -15.54 LETHAL n: 28 f: 6.2e-04 bk_f: 1.7e-04 p: -18.16 IMPLICATED n: 26 f: 5.7e-04 bk_f: 1.3e-04 p: -21.80 PHENOTYPES n: 25 f: 5.5e-04 bk_f: 1.7e-04 p: -15.10 HOMOLOG n: 25 f: 5.5e-04 bk_f: 1.6e-04 p: -15.88 ENZYME n: 22 f: 4.9e-04 bk_f: 1.5e-03 p: -24.59 PROTEIN-PROTEIN n: 20 f: 4.4e-04 bk_f: 5.5e-05 p: -26.69 FILAMENTS n: 19 f: 4.2e-04 bk_f: 3.9e-05 p: -30.35 IMMUNOPRECIPITATION n: 18 f: 4.0e-04 bk_f: 4.5e-05 p: -25.52 INTERACTED n: 17 f: 3.8e-04 bk_f: 3.9e-05 p: -25.42 CASCADE n: 17 f: 3.8e-04 bk_f: 5.2e-05 p: -21.42 ASSOCIATES n: 17 f: 3.8e-04 bk_f: 4.0e-05 p: -25.15 PHYSICALLY n: 16 f: 3.5e-04 bk_f: 4.1e-05 p: -22.62 SEQUENCES n: 15 f: 3.3e-04 bk_f: 1.1e-03 p: -17.91 LETHALITY n: 15 f: 3.3e-04 bk_f: 5.9e-05 p: -15.85 UBIQUITINATION n: 12 f: 2.7e-04 bk_f: 3.3e-05 p: -16.79 FILAMENT n: 12 f: 2.7e-04 bk_f: 2.4e-05 p: -20.26 POLYMERIZATION n: 11 f: 2.4e-04 bk_f: 3.4e-05 p: -14.26 LOCALIZES n: 11 f: 2.4e-04 bk_f: 2.8e-05 p: -16.21 LOCALIZE n: 11 f: 2.4e-04 bk_f: 3.4e-05 p: -14.42 SYNTHETICALLY n: 10 f: 2.2e-04 bk_f: 9.2e-06 p: -24.23 COACTIVATOR n: 9 f: 2.0e-04 bk_f: 1.6e-05 p: -16.18 SCREENS n: 8 f: 1.8e-04 bk_f: 1.5e-05 p: -14.35 CO-IMMUNOPRECIPITATION n: 8 f: 1.8e-04 bk_f: 9.2e-06 p: -17.99 UBIQUITIN-PROTEIN n: 7 f: 1.5e-04 bk_f: 9.2e-06 p: -15.04 P n: 6 f: 1.3e-04 bk_f: 7.4e-04 p: -18.84 RESPECTIVELY n: 5 f: 1.1e-04 bk_f: 5.8e-04 p: -14.54 BUD-SITE n: 5 f: 1.1e-04 bk_f: 2.7e-06 p: -15.37 PROTEIN-ASSOCIATED n: 4 f: 8.8e-05 bk_f: 1.2e-06 p: -14.93 CDNA n: 4 f: 8.8e-05 bk_f: 7.4e-04 p: -22.82 CONCENTRATION n: 2 f: 4.4e-05 bk_f: 4.3e-04 p: -14.39 SPECIES n: 1 f: 2.2e-05 bk_f: 7.2e-04 p: -29.91